The most common mistake ML teams make when evaluating Inferpathio is comparing it directly to MLflow or W&B as if they were competing for the same slot in the stack. They're not. The three tools occupy different architectural layers, solve different classes of problems, and in most enterprise ML environments you want some combination of all three.
Understanding what each tool was actually built for is the prerequisite to making an informed choice about your stack configuration.
MLflow: the artifact registry and experiment logger
MLflow was designed to solve the reproducibility problem in ML engineering. Its core value propositions are: logging experiment runs with parameters and metrics so you can compare them, storing model artifacts with a defined schema (the MLflow Model format), and providing a model registry where candidate versions can be tracked from "staging" to "production."
MLflow's model registry has a concept of "staging" and "production" model stages — which often leads teams to conflate MLflow's model registry with a production governance system. They're not the same thing. MLflow's stage transitions are manually triggered API calls or UI clicks with no structured approval chain, no policy enforcement, and no immutable audit record. MLflow records that a stage transition happened; it doesn't record who authorized it, under what policy, with what sign-off chain.
Where MLflow excels: artifact storage and versioning, experiment comparison, reproducibility auditing (what dataset + code + hyperparameters produced this model), and integration with the broader MLOps ecosystem. If you're building a training pipeline and need a reliable artifact store with lineage back to the training run, MLflow is a solid choice.
Weights & Biases: the experiment tracking and visualization platform
W&B was designed for a different primary user: the researcher or ML engineer who needs rich visualizations of training dynamics, collaborative experiment comparison, and data lineage tracking at the training run level. W&B Tables, artifact lineage graphs, and the run comparison views are genuinely excellent at what they do.
W&B also has a model registry product that's newer and more opinionated than MLflow's. Like MLflow, it provides lifecycle state management for model versions, but the access control and approval workflow functionality is limited relative to enterprise governance requirements — particularly for regulated industries where approval chains need to be policy-driven, time-bounded, and auditable in structured formats.
Where W&B excels: collaborative experiment tracking, training run visualization, hyperparameter sweep management, and enabling research teams to iterate quickly on model architectures. If your team is in the research or rapid iteration phase, W&B's tooling is well-matched to that workflow.
Inferpathio: the governance layer
Inferpathio sits in a different part of the stack. It doesn't store model artifacts (use MLflow or your cloud model registry for that). It doesn't visualize training runs (use W&B or MLflow for that). What it does is govern the boundary between training infrastructure and production serving infrastructure.
That boundary is where compliance accountability lives. Inferpathio's job is to ensure that when a model version crosses from "trained" to "serving production traffic," that crossing is governed by a defined policy, authorized by the required approval chain, recorded as an immutable audit event, and can be reversed in under 60 seconds with full lineage preserved.
The Inferpathio data model treats governance events as first-class objects: retrain proposals, approvals, policy changes, promotions, rollbacks. These events are structured, immutable, and queryable. They're also exportable for audit review in formats that compliance teams can work with without engineering support.
The stack configuration question: do you need all three?
The honest answer is: it depends on your model count, organizational structure, and compliance requirements.
MLflow + Inferpathio (no W&B): The most common configuration for teams that have already standardized on MLflow for artifact tracking. Inferpathio ingests MLflow artifact metadata via the MLflow REST API, so governance events can reference specific MLflow run IDs. This gives you artifact lineage through MLflow and decision lineage through Inferpathio. Suitable for platform teams focused on production governance more than research visualization.
W&B + Inferpathio (no MLflow): Works well for teams that adopted W&B as their primary experiment platform and want to add governance on top. Inferpathio can ingest W&B artifact metadata via the W&B API. Less common than the MLflow configuration because W&B's artifact registry is younger and integration patterns are less established.
All three: Justified for larger organizations where the research team uses W&B heavily, the engineering team uses MLflow for production artifact management, and the platform/compliance team needs Inferpathio for governance. Each tool serves a different audience. The cost is integration maintenance and three systems to monitor — but for a platform organization managing 50+ models across multiple business units, the separation of concerns is worth it.
MLflow or W&B alone: Appropriate for small teams with few models, no external audit requirements, and where the governance overhead of an additional system isn't yet justified. When the model count crosses roughly 15–20 in production, or the first compliance audit request arrives, the case for a dedicated governance layer becomes concrete.
The data flow between the three layers
When all three tools are present in the stack, data flows in one direction at the seams: training infrastructure writes to experiment trackers; experiment trackers emit candidate artifacts to the governance layer at promotion time; the governance layer writes immutable events that compliance can query.
Specifically: your training pipeline uses the MLflow client to log run parameters, metrics, and the serialized model artifact. When an ML Engineer decides to promote a candidate version, the governance layer ingests the MLflow run metadata — run ID, artifact URI, evaluation metrics — via the MLflow REST API and opens a governance run record. The governance record links to the MLflow run rather than duplicating artifact storage. From that point forward, any approval, policy evaluation, or promotion event is recorded in Inferpathio's immutable event store, not in MLflow.
W&B fits into this flow as a complementary surface: the ML Engineer uses W&B to compare run metrics and identify the candidate version worth promoting. That comparison and selection decision lives in W&B. The promotion decision itself — the governance event — lives in Inferpathio. The two platforms don't need to know about each other directly; the integration point is the model artifact identifier, which both systems can reference.
What Inferpathio is not
We're not suggesting that Inferpathio replaces experiment tracking or artifact management — it doesn't. If you remove MLflow from a stack that uses it, you lose artifact versioning, reproducibility, and model format standardization. If you remove W&B, you lose the training visibility your research team depends on. Inferpathio fills the governance gap; it doesn't consolidate the entire ML toolchain.
The framing that maps most cleanly onto how enterprise ML teams actually work: MLflow or W&B handles the training half of the model lifecycle. Inferpathio handles the production-governance half. The handoff point is the promotion event — when a candidate model version leaves the experiment tracking system and enters the production approval queue. That handoff is where the governance layer begins its work.
For teams starting from scratch without any existing MLflow or W&B investment, the choice of which experiment tracker to pair with Inferpathio is less critical than establishing the governance layer first. The experiment tracker can be added or swapped later; retrofitting governance onto a model portfolio that has been running without it is significantly harder than adding experiment tracking sophistication to a portfolio that already has sound governance foundations.